In the course of studying the control of blood glucose in juvenile onset diabetics, we developed convenient methods for determining /3-hydroxybutyrate and acetoacetate. Here we describe fixed-time, enzymic, reaction-rate procedures for directly measuring these organic ackis with a centrifugal analyzer (Rotochem llA/36) or a computerbacked spectrophotometer (Gilford 102 system). In either case, the method requires only 20 tL of plasma; is rapid, accurate, and precise; and analytical recovery is quantitative. Data are presented comparing resutts obtained with both instruments. Metabolic acidosis can be rapidly assessed and monitored with these methods, as illustrated by an example. 
Materials and Methods

Apparatus
Procedures
Centrifugal analyzer method. Before each run, the transfer disc and cuvette assembly were rinsed according to the manufacturer's instructions. Subsequently, the transfer disc was loaded according to Table 1 . The transfer disc was covered and allowed to stand for 3 mm at room temperature.
After it was loaded into the analyzer, the run was initiated through the computer according to The microprocessor unit and the spectrophotometer were programmed according to Table 3 . The vacuum gauge was set at 7-8 mmHg and the sample time for the flow-cell was set at 2. For each testing position, the fluids were delivered according to Table 4 , and the absorbance was read immediately. The data were computed by using the supplier's "kinetic substrate"
program: Regular insulin (10 mt. units/rn2 of body surface) was given intramuscularly an hour after admission and at hourly intervals thereafter until the blood glucose concentration declined to <3 g/L. When the blood glucose concentration reached 2 to 3 g/L, the intramuscular insulin dose was decreased to 5 mt. units/m2. Below 2 g/L, this dose of insulin was administered subcutaneously and repeated every 4-6 has required to keep the blood glucose concentration below 2 g/L.
Study specimens were collected at 1-h intervals for 26 h. All blood specimens were collected from an arm vein by way of an indwelling "scalp-vein" needle, which was attached to a small polyethylene catheter. Specimens were analyzed for several metabolites and hormones. Concurrent with insulin therapy, hydration of the patient was begun with intravenous infusion of a glucose/electrolyte fluid (50 g/L glucose inAbbott no. 2) at a rate of 250 mL/m2 per hour. After the first 8 h and during the rest of the infusion, the glucose concentration was increased to 100 g/L but at half of the previous infusion rate. Potassium phosphate, 15 to 25 mmol/L, was added as a supplement to all fluids.
Results and Discussion
Analytical Variables
Assay modes. These /3-hydroxybutyrate and acetoacetate assays were developed as fixed-time kinetic procedures, the reaction being linear between 20 to 60 s for /3-hydroxybutyrate and 20 to 70 s for acetoacetate.
The kinetic mode provided blanking for the intrinsic absorbance, thus eliminating the need for specimen blank. The direct kinetic approach also effectively eliminated the time-consuming filtrate-preparation step, thus it was practical for rapid use. A 20-s preincubation was required to complete the side reactions for both analytical systems.
The reading times shown in Tables 2 and 3 were chosen to allow the largest instrument responses that also provided linear relationships with respect to our analytical ranges at various concentrations.
Linearity.
The /3-hydroxybutyrate procedure described gave a linear standard curve between 0.02 and 5.0 mmol/L on both instruments for both aqueous standards and plasma with concentrations in the range 0.5 to 4.0 mmol/L were studied in duplicate by both methods. In the case of acetoacetate, in the range of 0.5 to 2.0 mmol/L, recovery was similarly evaluated. The results are summarized in Table 5 .
Precision.
Within-run precision was assessed by running replicates of normal and above-normal specimens. Day-to-day precision was estimated from the same material, which had been apportioned and stored frozen. All specimens were analyzed within the stability periods described above, Beyond these periods, both organic acids deteriorated, the acetoacetate more so. The results are summarized in Table 6 .
Interference.
We evaluated the specificity of our assays with respect to "ketone bodies," hemolysis, lipid contents, and other metabolites, with the Gilford 102 system. Concomitant increases in these were encountered occasionally, owing to pathological or laboratory conditions, All studies were performed with pooled plasma supplemented with the various constituents of interest (Table 7) . Drug interference was not investigated. 
Comparison of Methods
